20-F/A - BGM Group Ltd. (0001779578) (Filer)

20-F - BGM Group Ltd. (0001779578) (Filer)

6-K - BGM Group Ltd. (0001779578) (Filer)

SCHEDULE 13D - BGM Group Ltd. (0001779578) (Subject)

6-K - BGM Group Ltd. (0001779578) (Filer)

6-K - BGM Group Ltd. (0001779578) (Filer)

EFFECT - BGM Group Ltd. (0001779578) (Filer)

F-3 - BGM Group Ltd. (0001779578) (Filer)

6-K - Qilian International Holding Group (0001779578) (Filer)

6-K/A - Qilian International Holding Group Ltd (0001779578) (Filer)

SC 13D - BGM Group Ltd. (0001779578) (Subject)

SC 13D/A - BGM Group Ltd. (0001779578) (Subject)

SC 13D - Qilian International Holding Group Ltd (0001779578) (Subject)

CHENGDU, China, Feb. 19, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) announced the establishment of the "Duxiaobao Management Committee," which will be fully responsible for the management and decision-making of the "Duxiaobao" ecosystem. This move signifies BGM Group's strategic entry into the field of artificial intelligence, aiming to accelerate the transformation of the insurance industry into the smart era through AI technology. The Duxiaobao Management Committee consists of industry leaders such as Xin Chen, Li Yuqing, Ge Peng, Zhao Qi, Ren Yong, Li Jun, Zhou Xin, and Wang Hui. The committee has appointed Li Yuqing as the CEO of Duxiaobao, with Li Jun, Ren Yong, Zhou Xin, and Tan

CHENGDU, China, Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) (the "Company" or "BGM"), a leading global pharmaceutical enterprise, today announced completion of the acquisition of the intelligent platform of AIX Inc. It marks BGM's official entry into the domains of AI intelligent technology and financial/insurance services, opening up new opportunities for the integrated development of healthcare, pharmaceuticals, and insurance on a global scale. Through the acquisition of RONS Technology and Xinbao Investment, BGM will be able to integrate resources in intelligent technology and biopharmaceuticals, strengthening its market competitiveness at the intersection of healthcare tec

CHONGQING, China, Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Stock Code: BGM) has successfully acquired Rongshu Technology and Xinbao Investment Company, both subsidiaries of AIX Corp. (Stock Code: AIFU), in a transaction valued at approximately $140 million. This acquisition presents substantial opportunities for BGM Group's AI-driven insurance business. 1. Building an Efficient Equity Structure to Enhance Synergies With the completion of this acquisition, AIFU will officially become a shareholder of BGM Group. Under the astute leadership of CEO Mr. Xin Chen, Rongshu Technology and Xinbao Investment Company will work collaboratively to fully harness and unlock BGM Group's growth potenti

GUANGZHOU, China, Dec. 27, 2024 (GLOBE NEWSWIRE) -- AIX Inc. (the "Company" or AIX) (NASDAQ:AIFU), a leading independent technology-driven financial services provider in China, today announced the successful completion of its strategic share exchange transaction with BGM Group Ltd. (BGM) (NASDAQ:BGM), marking a significant milestone in its long-term transformation within the AI-driven insurance and healthcare space, and establishing a strong foundation for its future diversified growth. As part of the transaction, AIX transferred its intelligent insurance platform, including RONS Intelligent Technology (Beijing) Co., Ltd. ("RONS Technology"), to BGM in exchange for 69,995,661 Class A ordi

CHENGDU, China, Dec. 19, 2024 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) ("the Company" or "BGM"), Mr. Xin Zhanchang, Chairman of the Board of Directors of BGM Group and Chairman of Gansu Qilianshan Pharmaceutical Co., Ltd., led the sales team to visit their long-term strategic partner, Jointown Pharmaceutical Group. They were warmly welcomed by Mr. Liu Shulin, one of the founders and Honorary Vice Chairman of Jointown, along with Vice Chairman Mr. Liu Dengpan and other senior executives. The two sides held a cordial, productive meeting, further consolidating and deepening their strategic partnership. They also signed a strategic cooperation agreement for Qilianshan Pharmaceutical's licoric

In the news release, BGM Group Ltd. Pioneers Innovation in AI and Intel Technology, Fostering Holistic Integration of Healthcare and Insurtech, issued 29-Nov-2024 by BGM Group Ltd over PR Newswire, we are advised by the company that the headline should read "[BGM Group Ltd Pioneers Innovation in AI Technology, Fostering Holistic Integration of Healthcare and Insurtech]" rather than "[BGM Group Ltd. Pioneers Innovation in AI and Intel Technology, Fostering Holistic Integration of Healthcare and Insurtech]" as originally issued inadvertently. The complete, corrected release follows: BGM Group Ltd Pioneers Innovation in AI Technology, Fostering Holistic Integration of Healthcare and Insurtech

HONG KONG, Nov. 29, 2024 /PRNewswire/ -- AIX Inc. (NASDAQ:AIFU) is a leading company focused on insurance agency and claims services. Recently, the company has been gradually pushing for an intelligent and diversified transformation, aiming to capture growth opportunities in the AI insurance and healthcare sectors. The restructuring of its high-quality assets and a strategic partnership with BGM Group Ltd. (NASDAQ:BGM) are expected to create a second growth curve for the company's future performance. 1. Restructuring Quality Assets to Build a Smarter Future AIFU has recently undertaken the restructuring of its core assets, involving an amount of $140 million, including RONS Intelligent Tech

CHENGDU, China, Nov. 29, 2024 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) ("the Company" or "BGM"), a leading global pharmaceutical enterprise, today announced its acquisition of the intelligent platform of AIX Inc. (NASDAQ:AIFU) ("AIX") valued at 1 billion RMB (approximately $140 million). The intelligent platform encompasses AIX's subsidiaries – RONS Intelligent Technology (Beijing) Co., Ltd. ("RONS Technology") and Shenzhen Xinbao Investment Management Co., Ltd. ("Xinbao Investment"). Completion of the transaction is anticipated by the end of 2024. Through this strategic acquisition, BGM formally ventures into the domains of AI intelligent technology and financial and insurance services,

GUANGZHOU, China, Nov. 29, 2024 (GLOBE NEWSWIRE) -- AIX Inc. (NASDAQ:AIFU) (the "Company" or "AIX"), a leading independent technology-driven financial services provider in China, today announced that it has entered into a strategic transaction agreement (the "Agreement") with BGM Group Ltd. (NASDAQ:BGM) ("BGM"), a leading global provider of premium pharmaceutical products and services. Pursuant to the Agreement, AIX agreed to transfer the equity interests of its intelligent platform consisting of RONS Intelligent Technology (Beijing) Co., Ltd. ("RONS Technology") and Shenzhen Xinbao Investment Management Co., Ltd. ("Xinbao Investment"), valued at approximately US$140.0 million, to BGM in e

CHENGDU, China, Nov. 22, 2024 /PRNewswire/ -- On November 19, Qilianshan Pharmaceutical Co., Ltd. (Qilian Pharma), a subsidiary of BGM Group Ltd, welcomed a team of experts from Guilin Pharmaceutical Co., Ltd. (Guilin Pharma), including Quality Assurance Engineer Ms. Shen and Technical Manager Ms. An. The purpose of their visit was to conduct an on-site audit to pave the way for future cooperation between the two companies. Guilin Pharma, a member company of Fosun Pharma, is a comprehensive pharmaceutical enterprise specializing in the research, development, production, and sales of chemical drugs. With a product portfolio that includes tablets, capsules, injections, and active pharmaceutic

CHENGDU, China, Feb. 19, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) announced the establishment of the "Duxiaobao Management Committee," which will be fully responsible for the management and decision-making of the "Duxiaobao" ecosystem. This move signifies BGM Group's strategic entry into the field of artificial intelligence, aiming to accelerate the transformation of the insurance industry into the smart era through AI technology. The Duxiaobao Management Committee consists of industry leaders such as Xin Chen, Li Yuqing, Ge Peng, Zhao Qi, Ren Yong, Li Jun, Zhou Xin, and Wang Hui. The committee has appointed Li Yuqing as the CEO of Duxiaobao, with Li Jun, Ren Yong, Zhou Xin, and Tan